Literature DB >> 7513682

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.

H Ueda1, H Nakajima, Y Hori, T Fujita, M Nishimura, T Goto, M Okuhara.   

Abstract

A novel antitumor bicyclic depsipeptide, FR901228, was isolated from a broth culture of Chromobacterium violaceum No. 968 as colorless prisms and the molecular formula was determined as C24H36N4O6S2. This antibiotic reverted the transformed morphology of a Ha-ras transformant to normal, and exhibited prominent antitumor activities against murine and human tumor cell lines both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513682     DOI: 10.7164/antibiotics.47.301

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  100 in total

Review 1.  Macrocyclic histone deacetylase inhibitors.

Authors:  Sandra C Mwakwari; Vishal Patil; William Guerrant; Adegboyega K Oyelere
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 2.  Novel therapies in peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2008-10       Impact factor: 3.952

3.  New insights into the genetic organization of the FK228 biosynthetic gene cluster in Chromobacterium violaceum no. 968.

Authors:  Vishwakanth Y Potharla; Shane R Wesener; Yi-Qiang Cheng
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

Review 4.  Discovery of novel drug targets and their functions using phenotypic screening of natural products.

Authors:  Junghwa Chang; Ho Jeong Kwon
Journal:  J Ind Microbiol Biotechnol       Date:  2015-09-12       Impact factor: 3.346

5.  Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264.

Authors:  Cheng Wang; Creston J Flemming; Yi-Qiang Cheng
Journal:  Medchemcomm       Date:  2012-08-01       Impact factor: 3.597

Review 6.  Discovery and mechanism of natural products as modulators of histone acetylation.

Authors:  Lilibeth A Salvador; Hendrik Luesch
Journal:  Curr Drug Targets       Date:  2012-07       Impact factor: 3.465

Review 7.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

8.  Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304).

Authors:  Gregory A Otterson; Lydia Hodgson; Herbert Pang; Everett E Vokes
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

9.  Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold.

Authors:  Albert A Bowers; Nathan West; Tenaya L Newkirk; Annie E Troutman-Youngman; Stuart L Schreiber; Olaf Wiest; James E Bradner; Robert M Williams
Journal:  Org Lett       Date:  2009-03-19       Impact factor: 6.005

Review 10.  Genome-guided discovery of diverse natural products from Burkholderia sp.

Authors:  Xiangyang Liu; Yi-Qiang Cheng
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-09       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.